$1.2 Billion From U.S. to Drugmaker to Pursue Coronavirus Vaccine. Vaccination and Immunization, Coronavirus (2019-nCoV), Research, Clinical Trials, Drugs (Pharmaceuticals), AstraZeneca PLC, Biomedical Advanced Research and Development Authority, Health and Human Services Department, your-feed-healthcare